Allergan Inc v. Merz Pharmaceuticals LLC et al, No. 8:2011cv00446 - Document 441 (C.D. Cal. 2013)
Court Description: FINAL JUDGMENT Pursuant to Fed.R.Civ.Proc. 58 by Judge Andrew J. Guilford. (twdb)
Download PDF
<![CDATA[
Allergan Inc v. Merz Pharmaceuticals LLC et al Doc. 441 1 2 3 4 5 6 7 8 9 UNITED STATES DISTRICT COURT 10 11 CENTRAL DISTRICT OF CALIFORNIA - WESTERN DIVISION 12 13 ALLERGAN, INC., a Delaware Corporation, 14 15 16 17 Plaintiff, v. MERZ PHARMACEUTICALS, LLC, a North Carolina corporation, et al., 20 23 24 FINAL JUDGMENT PURSUANT TO FED. R. CIV. PROC. 58 MERZ PHARMACEUTICALS, LLC, a North Carolina Corporation, Counterclaimants, 21 22 Assigned for all purposes to Honorable Andrew J. Guilford Defendant. 18 19 Case No. SACV 11-446 AG (Ex) v. ALLERGAN, INC., a Delaware corporation, Counterdefendant. 25 26 27 28 FINAL JUDGMENT SACV 11-499 AG (Ex) Dockets.Justia.com 1 2 FINAL JUDGMENT Pursuant to Federal Rule of Civil Procedure 58, final judgment shall be 3 entered in this action pursuant to this Court’s Orders entered on February 1, 4 2012 (Dkt. No. 207), March 9, 2012 (Dkt. No. 286), May 7, 2012 (Dkt. Nos. 5 322 and 324), October 1, 2012 (Dkt. No. 368), and October 10, 2012 (Dkt. 6 No. 371), and in light of the fact that Merz Pharmaceuticals, LLC and Merz 7 Aesthetics, Inc. have filed their Second Status Report Regarding Corporate 8 Compliance Program on March 8, 2013 (Dkt. No. 436). 9 All parties shall bear their own fees and costs. 10 11 IT SO ORDERED. 12 13 Dated: May 14, 2013_____ 14 Hon. Andrew J. Guilford United States District Judge 15 16 17 18 19 20 21 22 23 24 25 26 27 28 -1- FINAL JUDGMENT SACV 11-499 AG (Ex)
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
